|
1
|
Worni M, Shah KN and Clary BM: Colorectal
cancer with potentially resectable hepatic metastases: optimizing
treatment. Curr Oncol Rep. 16:4072014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moon RT, Brown JD and Torres M: WNTs
modulate cell fate and behavior during vertebrate development.
Trends Genet. 13:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peifer M and Polakis P: Wnt signaling in
oncogenesis and embryogenesis - a look outside the nucleus.
Science. 287:1606–1609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller JR: The Wnts. Genome Biol.
3:REVIEWS3001. 2002.
|
|
5
|
Bejsovec A: Wnt signaling: an
embarrassment of receptors. Curr Biol. 10:R919–R922. 2000.
View Article : Google Scholar
|
|
6
|
Pandur P and Kühl M: An arrow for wingless
to take-off. BioEssays. 23:207–210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kühl M, Sheldahl LC, Park M, Miller JR and
Moon RT: The Wnt/Ca2+ pathway: a new vertebrate Wnt
signaling pathway takes shape. Trends Genet. 16:279–283. 2000.
View Article : Google Scholar
|
|
8
|
Weston CR and Davis RJ: The JNK signal
transduction pathway. Curr Opin Genet Dev. 12:14–21. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saitoh T and Katoh M: Molecular cloning
and characterization of human WNT5B on chromosome 12p13.3 region.
Int J Oncol. 19:347–351. 2001.PubMed/NCBI
|
|
10
|
Saitoh T and Katoh M: Expression and
regulation of WNT5A and WNT5B in human cancer: up-regulation of
WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by
beta-estradiol in MCF-7 cells. Int J Mol Med. 10:345–349.
2002.PubMed/NCBI
|
|
11
|
Mangioni S, Viganò P, Lattuada D, Abbiati
A, Vignali M and Di Blasio AM: Overexpression of the Wnt5b gene in
leiomyoma cells: implications for a role of the Wnt signaling
pathway in the uterine benign tumor. J Clin Endocrinol Metab.
90:5349–5355. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takeshita A, Iwai S, Morita Y,
Niki-Yonekawa A, Hamada M and Yura Y: Wnt5b promotes the cell
motility essential for metastasis of oral squamous cell carcinoma
through active Cdc42 and RhoA. Int J Oncol. 44:59–68. 2014.
|
|
13
|
Páez D, Gerger A, Zhang W, Yang D, Labonte
MJ, Benhanim L, Kahn M, Lenz F, Lenz C, Ning Y, et al: Association
of common gene variants in the WNT/β-catenin pathway with colon
cancer recurrence. Pharmacogenomics J. 14:142–150. 2014. View Article : Google Scholar
|
|
14
|
Yang L, Perez AA, Fujie S, Warden C, Li J,
Wang Y, Yung B, Chen YR, Liu X, Zhang H, et al: Wnt modulates MCL1
to control cell survival in triple negative breast cancer. BMC
Cancer. 14:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Q, Shen HM and Ong CN: Inhibitory
effect of emodin on tumor invasion through suppression of activator
protein-1 and nuclear factor-kappaB. Biochem Pharmacol. 68:361–371.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Min KW, Kim DH, Do SI, Kim K, Lee HJ, Chae
SW, Sohn JH, Pyo JS, Oh YH, Kim WS, et al: Expression patterns of
stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic
factors in invasive ductal carcinoma of the breast. APMIS.
122:1196–1206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stellas D and Patsavoudi E: Inhibiting
matrix metalloproteinases, an old story with new potentials for
cancer treatment. Anticancer Agents Med Chem. 12:707–717. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.
|
|
19
|
Murphy DA and Courtneidge SA: The 'ins'
and 'outs' of podosomes and invadopodia: characteristics, formation
and function. Nat Rev Mol Cell Biol. 12:413–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Veeman MT, Axelrod JD and Moon RT: A
second canon. Functions and mechanisms of beta-catenin-independent
Wnt signaling. Dev Cell. 5:367–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shibata W, Maeda S, Hikiba Y, Yanai A,
Sakamoto K, Nakagawa H, Ogura K, Karin M and Omata M: c-Jun
NH2-terminal kinase 1 is a critical regulator for the
development of gastric cancer in mice. Cancer Res. 68:5031–5039.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakurai T, Maeda S, Chang L and Karin M:
Loss of hepatic NF-kappa B activity enhances chemical
hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1
activation. Proc Natl Acad Sci USA. 103:10544–10551. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sancho R, Nateri AS, de Vinuesa AG,
Aguilera C, Nye E, Spencer-Dene B and Behrens A: JNK signalling
modulates intestinal homeostasis and tumourigenesis in mice. EMBO
J. 28:1843–1854. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
She QB, Chen N, Bode AM, Flavell RA and
Dong Z: Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice
enhances skin tumor development by
12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 62:1343–1348.
2002.PubMed/NCBI
|
|
25
|
Tong C, Yin Z, Song Z, Dockendorff A,
Huang C, Mariadason J, Flavell RA, Davis RJ, Augenlicht LH and Yang
W: c-Jun NH2-terminal kinase 1 plays a critical role in
intestinal homeostasis and tumor suppression. Am J Pathol.
171:297–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kurayoshi M, Oue N, Yamamoto H, Kishida M,
Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is
correlated with aggressiveness of gastric cancer by stimulating
cell migration and invasion. Cancer Res. 66:10439–10448. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamanaka H, Moriguchi T, Masuyama N,
Kusakabe M, Hanafusa H, Takada R, Takada S and Nishida E: JNK
functions in the non-canonical Wnt pathway to regulate convergent
extension movements in vertebrates. EMBO Rep. 3:69–75. 2002.
View Article : Google Scholar
|
|
28
|
Nomachi A, Nishita M, Inaba D, Enomoto M,
Hamasaki M and Minami Y: Receptor tyrosine kinase Ror2 mediates
Wnt5a-induced polarized cell migration by activating c-Jun
N-terminal kinase via actin-binding protein filamin A. J Biol Chem.
283:27973–27981. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei W, Li H, Li N, Sun H, Li Q and Shen X:
WNT5A/JNK signaling regulates pancreatic cancer cells migration by
phosphorylating paxillin. Pancreatology. 13:384–392. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nishioka M, Ueno K, Hazama S, Okada T,
Sakai K, Suehiro Y, Okayama N, Hirata H, Oka M, Imai K, et al:
Possible involvement of WNT11 in colorectal cancer progression. Mol
Carcinog. 52:207–217. 2013. View
Article : Google Scholar
|
|
31
|
Ueno K, Hazama S, Mitomori S, Nishioka M,
Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R and Hinoda Y:
Down-regulation of frizzled-7 expression decreases survival,
invasion and metastatic capabilities of colon cancer cells. Br J
Cancer. 101:1374–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Winn RA, Marek L, Han SY, Rodriguez K,
Rodriguez N, Hammond M, Van Scoyk M, Acosta H, Mirus J, Barry N, et
al: Restoration of WNT-7a expression reverses non-small cell lung
cancer cellular transformation through frizzled-9-mediated growth
inhibition and promotion of cell differentiation. J Biol Chem.
280:19625–19634. 2005. View Article : Google Scholar : PubMed/NCBI
|
